| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/28/1997 | EP0775202A1 Human interleukin variants generated by alternative splicing |
| 05/28/1997 | EP0775158A1 Organic compounds |
| 05/28/1997 | EP0775141A1 Phenyl xanthine derivatives |
| 05/28/1997 | EP0775140A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents |
| 05/28/1997 | EP0775132A1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 05/28/1997 | EP0775131A2 Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects |
| 05/28/1997 | EP0775130A1 Method for the preparation of (+/-)-calanolide a and intermediates thereof |
| 05/28/1997 | EP0775118A1 Benzimidazole derivatives having dopaminergic activity |
| 05/28/1997 | EP0774974A1 Novel vaccine adjuvant and vaccine |
| 05/28/1997 | EP0774969A1 Hiv protease inhibitor combination |
| 05/28/1997 | CN1150805A Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/28/1997 | CN1150803A Pyrazolo and pyrrolopyridines |
| 05/28/1997 | CN1150802A Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 05/28/1997 | CN1150760A Methods for inducing T cell tolerance to tissue or organ graft |
| 05/28/1997 | CN1150758A Process for preparation of acanthoic acid and pharmaceutical composition comprising same |
| 05/28/1997 | CN1035006C Method for preparing peptide of effect having bradykinin-antagonistic agent |
| 05/27/1997 | US5633395 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/27/1997 | US5633283 Method for treating multiple sclerosis |
| 05/27/1997 | US5633280 Urethanes and ureas that induce cytokine production |
| 05/27/1997 | US5633279 5-substituted derivatives of mycophenolic acid |
| 05/27/1997 | US5633277 Antiinflammatory |
| 05/27/1997 | US5633257 Phosphodiesterase inhibitor |
| 05/27/1997 | US5633234 Lysosomal targeting of immunogens |
| 05/27/1997 | US5633227 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| 05/27/1997 | US5632988 Containing the specific amino acid sequence arg-arg-lys-trp-gln in their structure |
| 05/27/1997 | US5632983 Method for treating secondary immunodeficiency |
| 05/27/1997 | US5632981 Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 05/27/1997 | CA2131185C Substituted pipecolinic acid derivatives as hiv protease inhibitors |
| 05/22/1997 | WO1997018312A1 Chimeric oligomers having an rna-cleavage activity |
| 05/22/1997 | WO1997018307A1 Fas ligand fusion protein |
| 05/22/1997 | WO1997018300A2 Murine model for human carcinoma |
| 05/22/1997 | WO1997018239A1 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 05/22/1997 | WO1997018237A1 Chemokine from niddm pancreas |
| 05/22/1997 | WO1997018212A1 Aryl and heteroaryl purine compounds |
| 05/22/1997 | WO1997018208A1 Quinoline derivatives as type iv phosphodiesterase inhibitors |
| 05/22/1997 | WO1997018191A1 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents |
| 05/22/1997 | WO1997017989A1 Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation |
| 05/22/1997 | WO1997017983A1 Methods of treating disorders of non-visual sensory epithelia |
| 05/22/1997 | CA2237998A1 Chemokine from niddm pancreas |
| 05/22/1997 | CA2237558A1 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents |
| 05/22/1997 | CA2237528A1 Chimeric oligomers having an rna-cleavage activity |
| 05/22/1997 | CA2235126A1 Quinoline derivatives as type iv phosphodiesterase inhibitors |
| 05/22/1997 | CA2232876A1 Fas ligand fusion protein |
| 05/21/1997 | EP0774257A2 Use of piperazine and homopiperazine compounds for the inhibition of cellular adhesion and infiltration |
| 05/21/1997 | EP0774003A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 05/21/1997 | EP0773939A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 05/21/1997 | EP0773931A1 Quinoline derivatives as leukotriene antagonists |
| 05/21/1997 | EP0773790A1 Invariant chain compositions useful for treating autoimmune diseases |
| 05/21/1997 | EP0773786A1 Quinoa saponin compositions and methods of use |
| 05/21/1997 | EP0710135A4 Extracorporeal affinity adsorption devices |
| 05/21/1997 | EP0684829A4 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof. |
| 05/21/1997 | EP0642514B1 Bridged bis-aryl carbinol derivatives, compositions and methods of use |
| 05/21/1997 | EP0580738B1 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
| 05/21/1997 | CN1150428A Corticotropin releasing factor antagonists |
| 05/21/1997 | CN1150390A Glial mitogenic factors, their preparation and use |
| 05/21/1997 | CN1150389A Extracts of stephania tetrandra for inhibition of interleukin-6 production |
| 05/21/1997 | CN1150155A Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 05/21/1997 | CN1034938C Process for preparing 4H-naphtho [1,2-b] pyran compound |
| 05/20/1997 | US5631286 Compounds useful for treating allergic or inflammatory diseases |
| 05/20/1997 | US5631282 Triterpenes |
| 05/20/1997 | US5631268 Antiallergens, 5ht2 receptor antagonists |
| 05/20/1997 | US5631263 Use of delta opioid receptor antagonists to treat immunoregulatory disorders |
| 05/20/1997 | US5631235 Immunosuppressants, antiarthritics and autoimmune diseases |
| 05/20/1997 | US5631221 Pollenosis-inducing polypeptide, process for preparing the same, and uses thereof |
| 05/20/1997 | US5631219 Method of stimulating hematopoiesis with hemoglobin |
| 05/20/1997 | US5631010 Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1 |
| 05/15/1997 | WO1997017446A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 05/15/1997 | WO1997017084A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 05/15/1997 | WO1997017080A1 Germanium yeast human diet nutritional supplement |
| 05/15/1997 | WO1997017072A2 Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system |
| 05/15/1997 | WO1997017067A1 Sublingual and buccal administration of selegiline |
| 05/15/1997 | WO1997013781A3 Synthetic peptides that inhibit il-6 activity |
| 05/15/1997 | WO1997011668A3 TUMOR NECROSIS FACTOR ALPHA (TNF-α) INHIBITING PHARMACEUTICALS |
| 05/15/1997 | WO1997011093A3 Parainfluenza virus glycoproteins and vaccines |
| 05/15/1997 | DE19541405A1 Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen Use of flupirtine for the prophylaxis and therapy of diseases which are associated with impairment of the hematopoietic cell system |
| 05/15/1997 | CA2209484A1 Germanium yeast human diet nutritional supplement |
| 05/14/1997 | EP0773221A1 Stable crystalline tetrahydrofolic acid salts |
| 05/14/1997 | EP0773024A2 Use of N-substituted nicotinamide compounds for the treatment of acute and chronic inflammatory diseases |
| 05/14/1997 | EP0772689A2 Retroviral vectors having a reduced recombination rate |
| 05/14/1997 | EP0772677A1 T cell activation |
| 05/14/1997 | EP0772629A1 T cell epitopes of rye grass pollen allergen |
| 05/14/1997 | EP0772619A1 Immunomodulatory oligonucleotides |
| 05/14/1997 | EP0772610A1 Dihydrobenzofuranes |
| 05/14/1997 | EP0772596A1 INDOLIZINE sPLA2 INHIBITORS |
| 05/14/1997 | EP0772592A1 1H-INDOLE-1-FUNCTIONAL sPLA 2? INHIBITORS |
| 05/14/1997 | EP0772449A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 05/14/1997 | EP0772447A1 Chinese herbs extract |
| 05/14/1997 | EP0772445A1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients |
| 05/14/1997 | EP0772440A1 Carbon monoxide dependent guanylyl cyclase modifiers |
| 05/14/1997 | EP0772437A1 Compositions and methods for delivery of genetic material |
| 05/14/1997 | EP0772396A1 Method of regulating immune function |
| 05/14/1997 | EP0677111B1 Novel proteinaceous particles |
| 05/14/1997 | EP0644894B1 Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus |
| 05/14/1997 | EP0603305B1 Use of a thymosin in the treatment of hepatitis c |
| 05/14/1997 | CN1149887A Compounds and methods for stimulation and enhancement of protective immune responses and IL-12 production |
| 05/14/1997 | CN1149834A Cyclosporin containing composition and process for preparation |
| 05/14/1997 | CN1149828A Method for treating allergic rhinitis |
| 05/14/1997 | CN1149471A Nutrient for youngsters |
| 05/14/1997 | CN1034868C Preparing method for 6 alpha, 9 alpha-difluorido-progester-3,20-diones compound |
| 05/13/1997 | US5629337 Methods for treating asthma using optically pure (-)-zileuton |